Beersheva-based developer of revolutionary dietary supplements and drugs for the treatment and prevention of human metabolic bone disease, based on unique calcium-based bio-mineralogical substances used by crayfish during the mineral deposition processes that enable them to survive in freshwater environments low in minerals and calcium. Completed clinical trial that shows efficacy over current treatments. Seeking introduction to potential strategic partners with pharma market leaders and investors.
